These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31132233)

  • 1. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
    Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
    Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
    Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
    BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
    Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
    Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
    Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
    Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
    Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules.
    Ma G; Yang D; Li Y; Li M; Li J; Fu J; Peng Z
    Thorac Cancer; 2022 Dec; 13(23):3393-3401. PubMed ID: 36284506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH.
    Li Y; Ma G; Zhao P; Fu R; Gao L; Jiang X; Hu P; Ren T; Wu Y; Wang Z; Cui Z; Yang D
    Clin Chim Acta; 2018 Oct; 485():95-102. PubMed ID: 29940145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
    Zhong M; Zhang Y; Pan Z; Wang W; Zhang Y; Weng Y; Huang H; He Y; Liu O
    Technol Cancer Res Treat; 2021; 20():15330338211041465. PubMed ID: 34519585
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer.
    Chen YY; Xu GB
    Med Oncol; 2014 Dec; 31(12):240. PubMed ID: 25361883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
    Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer.
    Dong J; Zhu D; Tang X; Lu D; Qiu X; Li B; Lin D; Li L; Liu J; Zhou Q
    PLoS One; 2019; 14(7):e0220306. PubMed ID: 31348821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
    Chen X; Wang X; He H; Liu Z; Hu JF; Li W
    PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
    Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of peripheral blood circulating tumor cell detection in the diagnosis of thoracic diseases and the prediction of severity.
    Qi C; Xiong XZ
    Clin Exp Med; 2023 Oct; 23(6):2331-2339. PubMed ID: 36929453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.
    Zhang W; Duan X; Zhang Z; Yang Z; Zhao C; Liang C; Liu Z; Cheng S; Zhang K
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33905377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
    Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
    Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
    Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
    J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
    Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
    Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.